Biology subjects

Abbott, C.

Publications and source records attributed to Abbott, C..

3 recordsLinked to original sources

bioRxiv2022

Canonical and Replicable Multi-Scale Intrinsic Connectivity Networks in 100k+ Resting-State fMRI Datasets

Resting-state functional magnetic resonance imaging (rsfMRI) has shown considerable promise for improving our understanding of brain function and characterizing various mental and cognitive states in the healthy and disordered brain. However, the lack of accurate and precise estimations of comparable functional patterns across datasets, individuals, and ever-changing brain states in a way that captures both individual variation and inter-subject correspondence limits the clinical utility of rsfMRI and its application to single-subject analyses. We posit that using reliable network templates and advanced group-informed network estimation approaches to accurately and precisely obtain individualized (dynamic) networks that retain cross-subject correspondence while maintaining subject-specific information is one potential solution to overcome the aforementioned barrier when considering cross-study comparability, independence of subject-level estimates, the limited data available in single studies, and the low signal-to-noise ratio (SNR) of rsfMRI. Toward this goal, we first obtained a reliable and replicable network template. We combined rsfMRI data of over 100k individuals across private and public datasets and selected around 58k that meet quality control (QC) criteria. We then applied multi-model-order independent component analysis (ICA) and subsampling to obtain reliable canonical intrinsic connectivity networks (ICNs) across multiple spatial scales. The selected ICNs (i.e., network templates) were also successfully replicated by independently analyzing the data that did not pass the QC criteria, highlighting the robustness of our adaptive template to data quality. We next studied the feasibility of estimating the corresponding subject-specific ICNs using a multivariate-spatially constrained ICA as an example of group-informed network estimation approaches. The results highlight that several factors, including ICNs themselves, data length, and spatial resolution, play key roles in successfully estimating the ICNs at the subject level. Large-scale ICNs, in general, require less data to achieve a specific level of spatial similarity with their templates (as well as within- and between-subject spatial similarity). Moreover, increasing data length can reduce an ICNs subject-level specificity, suggesting longer scans might not always be desirable. We also show spatial smoothing can alter results, and the positive linear relationship we observed between data length and spatial smoothness (we posit that it is at least partially due to averaging over intrinsic dynamics or individual variation) indicates the importance of considering this factor in studies such as those focused on optimizing data length. Finally, the consistency in the spatial similarity between ICNs estimated using the full-length of data and subset of it across different data lengths may suggest that the lower within-subject spatial similarity in shorter data lengths is not necessarily only defined by lower reliability in ICN estimates; rather, it can also be an indication of brain dynamics (i.e., different subsets of data may reflect different ICN dynamics), and as we increase the data length, the result approaches the average (also known as static) ICN pattern, and therefore loses its distinctiveness.

neuroscience↗

bioRxiv2021

Neural excitation/inhibition imbalance and the treatment of severe depression

An influential hypothesis holds that depression is related to a neural excitation/inhibition imbalance, but its role in the treatment of depression remains unclear. Here, we show that unmedicated patients with severe depression demonstrated reduced inhibition of brain-wide resting-state networks relative to healthy controls. Patients using antidepressants showed inhibition that was higher than unmedicated patients and comparable to controls, but they still suffered from severe depression. Subsequent treatment with electroconvulsive therapy (ECT) reduced depressive symptoms, but its effectiveness did not depend on changes in network inhibition. Concomitant pharmacotherapy increased the effectiveness of ECT, but only when the strength of neural inhibition before ECT was within the normal range and not when inhibition was excessive. These findings suggest that reversing the excitation/inhibition imbalance may not be sufficient nor necessary for the effective treatment of severe depression, and that brain-state informed pharmacotherapy management may enhance the effectiveness of ECT.

neuroscience↗

bioRxiv2021

Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation

Major histocompatibility complex (MHC)-bound peptides that originate from tumor-specific genetic alterations, known as neoantigens, are an important class of anti-cancer therapeutic targets. Accurately predicting peptide presentation by MHC complexes is a key aspect of discovering therapeutically relevant neoantigens. Technological improvements in mass-spectrometry-based immunopeptidomics and advanced modeling techniques have vastly improved MHC presentation prediction over the past two decades. However, improvement in the sensitivity and specificity of prediction algorithms is needed for clinical applications such as the development of personalized cancer vaccines, the discovery of biomarkers for response to checkpoint blockade and the quantification of autoimmune risk in gene therapies. Toward this end, we generated allele-specific immunopeptidomics data using 25 mono-allelic cell lines and created Systematic HLA Epitope Ranking Pan Algorithm (SHERPA), a pan-allelic MHC-peptide algorithm for predicting MHC-peptide binding and presentation. In contrast to previously published large-scale mono-allelic data, we used an HLA-null K562 parental cell line and a stable transfection of HLA alleles to better emulate native presentation. Our dataset includes five previously unprofiled alleles that expand MHC binding pocket diversity in the training data and extend allelic coverage in underprofiled populations. To improve generalizability, SHERPA systematically integrates 128 mono-allelic and 384 multi-allelic samples with publicly available immunoproteomics data and binding assay data. Using this dataset, we developed two features that empirically estimate the propensities of genes and specific regions within gene bodies to engender immunopeptides to represent antigen processing. Using a composite model constructed with gradient boosting decision trees, multiallelic deconvolution and 2.15 million peptides encompassing 167 alleles, we achieved a 1.44 fold improvement of positive predictive value compared to existing tools when evaluated on independent mono-allelic datasets and a 1.15 fold improvement when evaluating on tumor samples. With a high degree of accuracy, SHERPA has the potential to enable precision neoantigen discovery for future clinical applications.

bioinformatics↗